Avaxia receives US patent with broad coverage over oral anti-TNF antibodies ... pharmabiz.com 8,647,626, entitled “Compositions Comprising TNF-specific Antibodies for Oral Delivery.” This patent covers milk-derived anti-TNF antibodies that are orally administered within a broad dose range for the treatment of inflammatory bowel disease (IBD). |
